Literature DB >> 8256884

Breathlessness during acute bronchoconstriction in asthma. Pathophysiologic mechanisms.

M D Lougheed1, M Lam, L Forkert, K A Webb, D E O'Donnell.   

Abstract

The purpose of this study was to examine potential contributing factors to breathlessness during bronchoconstriction, in particular, to evaluate the role of lung hyperinflation. We also wished to elucidate qualitative aspects of the unpleasant sensory experience and to identify factors that contribute to intersubject variability in subjective and objective assessments of airflow obstruction. We studied sensory-mechanical interrelationships during and after induced bronchoconstriction in 21 subjects with mild stable asthma. Breathlessness (Borg scale), spirometry, and inspiratory capacity (IC) were measured after each dose during methacholine bronchoprovocation to a maximal change (delta) in FEV1 of 50%. Breathing pattern, specific airway resistance (SRaw), plethysmographic thoracic gas volume, and maximal inspiratory mouth pressure (MIP) were recorded at baseline, at maximal response, and at full symptom recovery. End-expiratory lung volume (EELV) was derived from IC. Borg increased from 0.4 +/- 0.1 (very, very slight) at baseline to 5.0 +/- 0.5 (severe) at maximal bronchoconstriction (mean +/- SEM, p < 0.001). FEV1 fell significantly (p < 0.001) to 48% predicted at maximal response. Of the 21 subjects, 19 reported increased inspiratory rather than expiratory difficulty and predominantly described sensations of reduced inspiratory capacity and unrewarded inspiratory effort. Stepwise multiple regression analysis using delta Borg (outcome variable) versus changes in spirometry, SRaw, IC, and breathing pattern components, selected delta IC as the principal contributing factor: delta Borg = 0.09 (delta IC, %fall); n = 193, r = 0.86, p < 0.001. delta IC continued to contribute significantly (p < 0.001) to the variance in Borg ratings after accounting for delta FEV1, and it was the strongest predictor of symptom recovery (p < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8256884     DOI: 10.1164/ajrccm/148.6_Pt_1.1452

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  20 in total

Review 1.  Cough variant asthma: lessons learned from deep inspirations.

Authors:  M Diane Lougheed; Scott E Turcotte; Thomas Fisher
Journal:  Lung       Date:  2011-12-03       Impact factor: 2.584

2.  Asthma-like symptoms induced by the methacholine challenge test: do they predict a negative-to-positive switch in the test result?-case report.

Authors:  Abraham B Bohadana; Ariel Rokach; Pascal Wild; Gabriel Izbicki
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

Review 3.  Dyspnoea in the elderly: a clinical approach to diagnosis.

Authors:  J C Yernault
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 4.  COPD exacerbations . 3: Pathophysiology.

Authors:  D E O'Donnell; C M Parker
Journal:  Thorax       Date:  2006-04       Impact factor: 9.139

Review 5.  The effect of obesity on lung function.

Authors:  Anne E Dixon; Ubong Peters
Journal:  Expert Rev Respir Med       Date:  2018-08-14       Impact factor: 3.772

6.  Relation of the perception of airway obstruction to the severity of asthma.

Authors:  I D Bijl-Hofland; S G Cloosterman; H T Folgering; R P Akkermans; C P van Schayck
Journal:  Thorax       Date:  1999-01       Impact factor: 9.139

7.  An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.

Authors:  Mark B Parshall; Richard M Schwartzstein; Lewis Adams; Robert B Banzett; Harold L Manning; Jean Bourbeau; Peter M Calverley; Audrey G Gift; Andrew Harver; Suzanne C Lareau; Donald A Mahler; Paula M Meek; Denis E O'Donnell
Journal:  Am J Respir Crit Care Med       Date:  2012-02-15       Impact factor: 21.405

8.  Perception of bronchial obstruction in asthmatic patients. Relationship with bronchial eosinophilic inflammation and epithelial damage and effect of corticosteroid treatment.

Authors:  G L Roisman; C Peiffer; J G Lacronique; A Le Cae; D J Dusser
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Perception of airflow obstruction and associated breathlessness in normal and asthmatic subjects: correlation with anxiety and bronchodilator needs.

Authors:  L P Boulet; I Cournoyer; F Deschesnes; P Leblanc; A Nouwen
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139

Review 10.  Dyspnoea in health and obstructive pulmonary disease : the role of respiratory muscle function and training.

Authors:  Alison K McConnell; Lee M Romer
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.